Mutagenesis of Propionibacterium acnes and analysis of two CAMP factor knock-out mutants

Journal of Microbiological Methods

Volumn 83, Issue 2, 2010, Pages 211-216

  Sörensen, Meike ^a   Mak, Tim N ^a   Hurwitz, Robert ^b   Ogilvie, Lesley A ^a   Mollenkopf, Hans J ^c   Meyer, Thomas F ^a   Brüggemann, Holger ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b Protein Purification Core Facility   (Germany)

^c Microarray Core Facility   (Germany)

Author keywords

Acne vulgaris; Co hemolysin; Insertional mutagenesis; Propionibacterium acnes

Indexed keywords

CAMP FACTOR; CAMP FACTOR 2; CAMP FACTOR 4; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; CONTROLLED STUDY; GENE CASSETTE; GENE INACTIVATION; HEMOLYSIS; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MUTAGENESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BLOTTING, WESTERN; ERYTHROCYTES; ERYTHROMYCIN; GENE KNOCKOUT TECHNIQUES; HEMOLYSIN PROTEINS; HEMOLYSIS; MICE; MUTAGENESIS, INSERTIONAL; POLYMERASE CHAIN REACTION; PROPIONIBACTERIUM ACNES; RECOMBINATION, GENETIC; SELECTION, GENETIC; SHEEP;

BACTERIA (MICROORGANISMS); OVIS ARIES; PROPIONIBACTERIUM ACNES;

EID: 77957866084     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2010.09.008     Document Type: Article

References (23)

1. Bernheimer A.W., Linder R., Avigad L.S. Nature and mechanism of action of the CAMP protein of Group B streptococci. Infect. Immun. 1979, 23:838-844.
2. Bojar R.A., Holland K.T. Acne and Propionibacterium acnes. Clin. Dermatol. 2004, 22:375-379.
3. Brüggemann H., Henne A., Hoster F., Liesegang H., Wiezer A., Strittmatter A., et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 2004, 305:671-673.
4. Cheong D.E., Lee H.I., So J.S. Optimization of electrotransformation conditions for Propionibacterium acnes. J. Microbiol. Methods 2008, 72:38-41.
5. Choudhury T.K. Synergistic lysis of erythrocytes by Propionibacterium acnes. J. Clin. Microbiol. 1978, 8:238-241.
6. Christie R., Atkins N.E., Munch-Petersen E. A note on a lytic phenomenon shown by Group B streptococci. Aust. J. Exp. Biol. Med. Sci. 1944, 22:197-200.
7. Cogen A.L., Nizet V., Gallo R.L. Skin microbiota: a source of disease or defence?. Brit. J. Dermatol. 2008, 158:442-455.
8. Csukas Z., Banizs B., Rozgonyi F. Studies on the cytotoxic effects of Propionibacterium acnes strains isolated from cornea. Microb. Pathog. 2004, 36:171-174.
9. Dessinioti C., Katsambas A.D. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin. Dermatol. 2010, 28:2-7.
10. Hensler M.E., Quach D., Hsieh C.J., Doran K.S., Nizet V. CAMP factor is not essential for systemic virulence of Group B Streptococcus. Microb. Pathog. 2008, 44:84-88.
11. Hoeffler U. Enzymatic and hemolytic properties of Propionibacterium-acnes and related bacteria. J. Clin. Microbiol. 1977, 6:555-558.
12. Holland C., Mak T.N., Zimny-Arndt U., Schmid M., Meyer T.F., Jungblut P.R., Brüggemann H. Proteomic identification of secreted proteins of Propionibacterium acnes. BMC Microbiol. 2010, 10:230.
13. Jappe U., Ingham E., Henwood J., Holland K.T. Propionibacterium acnes and inflammation in acne: P-acnes has T-cell mitogenic activity. Brit. J. Dermatol. 2002, 146:202-209.
14. Jore J.P., van L.N., Luiten R.G., van der Werf M.J., Pouwels P.H. Efficient transformation system for Propionibacterium freudenreichii based on a novel vector. Appl. Environ. Microbiol. 2001, 67:499-503.
15. Jugeau S., Tenaud I., Knol A.C., Jarrousse V., Quereux G., Khammari A., et al. Induction of toll-like receptors by Propionibacterium acnes. Br. J. Dermatol. 2005, 153:1105-1113.
16. Kim J., Ochoa M.T., Krutzik S.R., Takeuchi O., Uematsu S., Legaspi A.J., et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 2002, 169:1535-1541.
17. Komoriya K. Flagellar proteins and type III-exported virulence factors are the predominant proteins secreted into the culture media of Salmonella typhimurium. Mol. Microbiol. 1999, 34:767-779.
18. Kurokawa I., Danby F.W., Ju Q., Wang X., Xiang L.F., Xia L., et al. New developments in our understanding of acne pathogenesis and treatment. Exp. Dermatol. 2009, 18:821-832.
19. Lang S.H., Palmer M. Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J. Biol. Chem. 2003, 278:38167-38173.
20. Litwin C.M., Johnson J.M. Identification, cloning, and expression of the CAMP-like factor autotransporter gene (cfa) of Bartonella henselae. Infect. Immun. 2005, 73:4205-4213.
21. Nagy I., Pivarcsi A., Koreck A., Szell M., Urban E., Kemeny L. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J. Invest. Dermatol. 2005, 124:931-938.
22. Suwannakham S., Huang Y., Yang S.T. Construction and characterization of ack knock-out mutants of Propionibacterium acidipropionici for enhanced propionic acid fermentation. Biotechnol. Bioeng. 2006, 94:383-395.
23. Valanne S., McDowell A., Ramage G., Tunney M.M., Einarsson G.G., O'Hagan S., et al. CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II. Microbiology 2005, 151:1369-1379.